MEDEXUS PHARMACEUTICALS INC (MDP.CA) Stock Analyst Earnings Estimates
TSX:MDP - Toronto Stock Exchange - CA58410Q2036 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 76.701M -3.71% | 108.096M 40.93% | 113.054M 4.59% | 109.31M -3.31% | 100.96M -7.64% | 125.13M 23.94% | 132.67M 6.03% | 138.23M 4.19% | 156.86M 13.48% | 83.213M -46.95% | 82.204M -1.21% | |
| EBITDA YoY % growth | -6.231M -209.70% | 14.57M 333.83% | 18.593M 27.61% | 18.983M 2.10% | 10.678M -43.75% | 22.123M 107.18% | 34.673M 56.73% | 46.45M 33.97% | 59.016M 27.05% | 15.836M -73.17% | 15.634M -1.28% | |
| EBIT YoY % growth | -12.376M -4,025.33% | 8.489M 168.59% | 12.787M 50.63% | 9.228M -27.83% | 2.372M -74.30% | 21.846M 820.99% | 27.54M 26.06% | 39.623M 43.87% | 52.615M 32.79% | 9.481M -81.98% | 9.279M -2.13% | |
| Operating Margin | -16.14% | 7.85% | 11.31% | 8.44% | 2.35% | 17.46% | 20.76% | 28.66% | 33.54% | 11.39% | 11.29% | |
| EPS YoY % growth | -1.27 -13.87% | -0.05 96.06% | -0.01 80.00% | 0.03 410.57% | -0.14 -547.15% | 0.44 420.00% | 0.91 104.41% | 0.65 -28.82% | 0.68 4.70% | 0.63 -7.47% | 0.60 -4.85% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 -293.58% | 0.03 -66.33% | 0.04 | 0.07 | 0.07 221.74% |
| Revenue Q2Q % growth | 25.412M -2.12% | 23.64M -13.35% | 24.457M -7.02% | 27.191M -9.34% | 26.1M 2.71% |
| EBITDA Q2Q % growth | 1.786M -79.31% | 3.064M -46.62% | 3.457M -51.21% | 4.514M -47.04% | 3.884M 117.47% |
| EBIT Q2Q % growth | 477.225K -83.11% | 1.288M -70.25% | 1.728M -57.85% | 3.725M -1.48% | 2.732M 472.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 100.00% | 0.00 | % | |
| Q2 2025 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | -100.00% |
| Q1 2025 Q2Q % growth | 0.08 166.67% | 0.04 | 0.04 | 98.02% |
| Q4 2024 Q2Q % growth | 0.03 -91.18% | -0.02 | 0.05 | 248.51% |
| Q3 2024 Q2Q % growth | -0.02 71.43% | 0.03 | -0.05 | -158.24% |
| Q2 2024 Q2Q % growth | -0.05 64.29% | 0.02 | -0.07 | -325.02% |
| Q1 2024 Q2Q % growth | 0.03 116.67% | -0.01 | 0.04 | 347.52% |
| Q4 2023 Q2Q % growth | 0.34 225.93% | -0.06 | 0.40 | 712.06% |
| Q3 2023 Q2Q % growth | -0.07 58.82% | -0.08 | 0.01 | 13.37% |
| Q2 2023 Q2Q % growth | -0.14 56.25% | -0.14 | 0.00 | 0.99% |
| Q1 2023 Q2Q % growth | -0.18 64.67% | -0.14 | -0.04 | -27.30% |
| Q4 2022 Q2Q % growth | -0.27 57.12% | -0.22 | -0.05 | -23.38% |
| Q3 2022 Q2Q % growth | -0.17 81.23% | -0.30 | 0.13 | 42.94% |
| Q2 2022 Q2Q % growth | -0.32 -898.84% | -0.26 | -0.06 | -21.36% |
| Q1 2022 Q2Q % growth | -0.51 -113.94% | -0.03 | -0.48 | -1,490.43% |
| Q4 2021 Q2Q % growth | -0.63 -463.99% | -0.02 | -0.61 | -3,843.42% |
| Q3 2021 Q2Q % growth | -0.91 -2,888.88% | 0.03 | -0.94 | -2,927.74% |
| Q2 2021 Q2Q % growth | -205.73% | -0.03 | % | |
| Q1 2021 Q2Q % growth | -0.24 -112.36% | 0.02 | -0.26 | -1,196.75% |
| Q4 2020 Q2Q % growth | -0.11 -64.92% | -0.06 | -0.05 | -77.95% |
| Q3 2020 Q2Q % growth | -0.03 -100.33% | -0.06 | 0.03 | 53.23% |
| Q2 2020 Q2Q % growth | 0.03 | -0.04 | 0.07 | 185.06% |
| Q1 2020 Q2Q % growth | -0.11 -24.61% | -0.10 | -0.01 | -8.06% |
| Q4 2019 Q2Q % growth | -0.07 | -0.15 | 0.09 | 56.08% |
| Q3 2019 Q2Q % growth | -0.02 | -0.23 | 0.21 | 93.37% |
| Q2 2019 Q2Q % growth | 0.00 | -0.12 | 0.12 | 100.00% |
| Q1 2019 Q2Q % growth | -0.09 | -0.15 | 0.06 | 41.62% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 29.992M 18.96% | 27.27M | 2.722M | 9.98% |
| Q2 2025 Q2Q % growth | 26.303M -13.27% | 26.405M | -102K | -0.39% |
| Q1 2025 Q2Q % growth | 27.283M -13.54% | 27.186M | 97K | 0.36% |
| Q4 2024 Q2Q % growth | 25.962M -9.33% | 27.026M | -1.064M | -3.94% |
| Q3 2024 Q2Q % growth | 25.211M -12.25% | 30.661M | -5.45M | -17.78% |
| Q2 2024 Q2Q % growth | 30.326M 9.54% | 30.658M | -332K | -1.08% |
| Q1 2024 Q2Q % growth | 31.555M 36.92% | 29.288M | 2.267M | 7.74% |
| Q4 2023 Q2Q % growth | 28.633M 41.31% | 28.497M | 136K | 0.48% |
| Q3 2023 Q2Q % growth | 28.731M 35.08% | 28.824M | -93K | -0.32% |
| Q2 2023 Q2Q % growth | 27.686M 54.66% | 24.846M | 2.84M | 11.43% |
| Q1 2023 Q2Q % growth | 23.046M 33.47% | 22.018M | 1.028M | 4.67% |
| Q4 2022 Q2Q % growth | 20.263M 775.43% | 18.658M | 1.605M | 8.60% |
| Q3 2022 Q2Q % growth | 21.27M -32.50% | 18.831M | 2.439M | 12.95% |
| Q2 2022 Q2Q % growth | 17.901M -24.24% | 18.093M | -192K | -1.06% |
| Q1 2022 Q2Q % growth | 17.267M -37.26% | 19.785M | -2.518M | -12.73% |
| Q4 2021 Q2Q % growth | -3M -111.71% | 21.72M | -24.72M | -113.81% |
| Q3 2021 Q2Q % growth | 31.51M 94.51% | 25.277M | 6.233M | 24.66% |
| Q2 2021 Q2Q % growth | 23.63M 44.09% | 19.785M | 3.845M | 19.43% |
| Q1 2021 Q2Q % growth | 27.52M 70.61% | 19.985M | 7.535M | 37.70% |
| Q4 2020 Q2Q % growth | 25.63M 101.18% | 14.361M | 11.269M | 78.47% |
| Q3 2020 Q2Q % growth | 16.2M 12.34% | 13.198M | 3.002M | 22.75% |
| Q2 2020 Q2Q % growth | 16.4M 375.36% | 13.858M | 2.542M | 18.34% |
| Q1 2020 Q2Q % growth | 16.13M 396.31% | 12.06M | 4.07M | 33.75% |
| Q4 2019 Q2Q % growth | 12.74M | 9.567M | 3.173M | 33.17% |
| Q3 2019 Q2Q % growth | 14.42M | 9.537M | 4.883M | 51.20% |
| Q2 2019 Q2Q % growth | 3.45M | 2.346M | 1.104M | 47.06% |
| Q1 2019 Q2Q % growth | 3.25M | 9.567M | -6.317M | -66.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -72.52% | -130% | -23.12% | -67.29% |
| Revenue | 3.14% | -13.54% | 2.94% | 3.01% |